HAE Earnings

Quarterly EPS
$0.66
Q2 2025
$0.75
Q3 2025
$1.18
Q4 2025
$0.71
Q1 2026
$0.81
Q2 2026
$0.96
Q3 2026
$-0.44
Q4 2026
$0.73
Q1 2027
Latest Revenue339.4M
Latest Net Income33.0M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027$0.73339.4M33.0M+5.6%+2.8%
Q4 2026-$0.44346.4M-20147000+4.8%-137.3%
Q3 2026$0.96339.0M44.7M-2.7%+28.0%
Q2 2026$0.81327.3M38.7M-5.3%+22.7%
Q1 2026$0.71321.4M34.0M-4.4%-5.3%
Q4 2025$1.18330.6M58.0M-3.7%+195.0%
Q3 2025$0.75348.5M37.5M+3.7%+21.0%
Q2 2025$0.66345.5M33.8M+8.6%+34.7%
Q1 2025$0.75336.2M38.4M
Q4 2024$0.40343.3M20.4M
Q3 2024$0.62336.3M31.2M
Q2 2024$0.49318.2M24.9M
Haemonetics (HAE) — Earnings